You can:
Name | Glucagon-like peptide 2 receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | GLP2R |
Synonym | GLP-2R GLP-2-R GLP-2 receptor |
Disease | Diarrhea Gastrointestinal disease Short bowel syndrome Osteoporosis Inflammatory bowel disease |
Length | 553 |
Amino acid sequence | MKLGSSRAGPGRGSAGLLPGVHELPMGIPAPWGTSPLSFHRKCSLWAPGRPFLTLVLLVSIKQVTGSLLEETTRKWAQYKQACLRDLLKEPSGIFCNGTFDQYVCWPHSSPGNVSVPCPSYLPWWSEESSGRAYRHCLAQGTWQTIENATDIWQDDSECSENHSFKQNVDRYALLSTLQLMYTVGYSFSLISLFLALTLLLFLRKLHCTRNYIHMNLFASFILRTLAVLVKDVVFYNSYSKRPDNENGWMSYLSEMSTSCRSVQVLLHYFVGANYLWLLVEGLYLHTLLEPTVLPERRLWPRYLLLGWAFPVLFVVPWGFARAHLENTGCWTTNGNKKIWWIIRGPMMLCVTVNFFIFLKILKLLISKLKAHQMCFRDYKYRLAKSTLVLIPLLGVHEILFSFITDDQVEGFAKLIRLFIQLTLSSFHGFLVALQYGFANGEVKAELRKYWVRFLLARHSGCRACVLGKDFRFLGKCPKKLSEGDGAEKLRKLQPSLNSGRLLHLAMRGLGELGAQPQQDHARWPRGSSLSECSEGDVTMANTMEEILEESEI |
UniProt | O95838 |
Protein Data Bank | N/A |
GPCR-HGmod model | N/A |
3D structure model | No available structures or models |
BioLiP | N/A |
Therapeutic Target Database | T34843 |
ChEMBL | CHEMBL5844 |
IUPHAR | N/A |
DrugBank | N/A |
Name | BDBM50398386 |
---|---|
Molecular formula | C121H194N32O37 |
IUPAC name | (2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-3-carboxy-2-[[(2S)-2-[[(2S,3S)-2-[[(2S,3R)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]butanedioic acid |
Molecular weight | 2689.07 |
Hydrogen bond acceptor | 40 |
Hydrogen bond donor | 38 |
XlogP | -9.9 |
Synonyms | N/A |
Inchi Key | QHVWMZIJTXDVMP-ACVSCHTLSA-N |
Inchi ID | InChI=1S/C121H194N32O37/c1-20-57(11)91(113(182)136-73(38-39-84(124)157)103(172)152-95(63(17)154)117(186)135-71(36-29-30-40-122)102(171)147-94(60(14)23-4)116(185)153-96(64(18)155)118(187)146-83(120(189)190)52-90(165)166)148-111(180)76(44-56(9)10)138-106(175)78(46-67-53-131-70-35-28-27-34-68(67)70)140-108(177)80(49-87(127)160)145-114(183)92(58(12)21-2)149-112(181)77(45-66-32-25-24-26-33-66)139-109(178)81(50-88(161)162)142-101(170)72(37-31-41-130-121(128)129)134-99(168)62(16)132-98(167)61(15)133-104(173)74(42-54(5)6)137-107(176)79(48-86(126)159)141-110(179)82(51-89(163)164)143-105(174)75(43-55(7)8)144-115(184)93(59(13)22-3)150-119(188)97(65(19)156)151-100(169)69(123)47-85(125)158/h24-28,32-35,53-65,69,71-83,91-97,131,154-156H,20-23,29-31,36-52,122-123H2,1-19H3,(H2,124,157)(H2,125,158)(H2,126,159)(H2,127,160)(H,132,167)(H,133,173)(H,134,168)(H,135,186)(H,136,182)(H,137,176)(H,138,175)(H,139,178)(H,140,177)(H,141,179)(H,142,170)(H,143,174)(H,144,184)(H,145,183)(H,146,187)(H,147,171)(H,148,180)(H,149,181)(H,150,188)(H,151,169)(H,152,172)(H,153,185)(H,161,162)(H,163,164)(H,165,166)(H,189,190)(H4,128,129,130)/t57-,58-,59-,60-,61-,62-,63+,64+,65+,69-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,91-,92-,93-,94-,95-,96-,97-/m0/s1 |
PubChem CID | 91928511 |
ChEMBL | CHEMBL2177393 |
IUPHAR | N/A |
BindingDB | 50398386 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
%max | 11.0 % | PMID22944117 | ChEMBL |
Activity | 88.0 % | PMID22944117 | ChEMBL |
Activity | 100.0 % | PMID22944117 | ChEMBL |
EC50 | 1300.0 nM | PMID22944117 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417